Welcome to the e-CCO Library!

P0234: Predicting factors for long-term outcomes of intestinal Behçet's disease in Japan
Year: 2025
Source: ECCO'25
Authors: Murakamix7x7x7 K.(1);Iharax7x7x7 S.(1)*;Fujishirox7x7x7 M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0235: Intestinal Ultrasound and Its Advanced Modalities in Characterizing Strictures in Crohn's Disease
Year: 2025
Source: ECCO'25
Authors: de Voogdx7x7x7 F.(1)*;Beekx7x7x7 K.(2);Pruijtx7x7x7 M.(1);Van Rijnx7x7x7 K.(2);van der Biltx7x7x7 J.(3);Buskensx7x7x7 C.(3);Bemelmanx7x7x7 W.(3);Neefjes-Borstx7x7x7 E.A.(4);Mookhoekx7x7x7 A.(5);D'Haensx7x7x7 G.(1);Stokerx7x7x7 J.(2);Gecsex7x7x7 K.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0236: Diaphragmatic ultrasound investigation to discriminate sarcopenic index in a population of patients with ibd
Year: 2025
Source: ECCO'25
Authors: Palmisanox7x7x7 C.M.(1)*;Dell'Aquilax7x7x7 P.(2);Cormiox7x7x7 S.(3);Borraccinox7x7x7 A.V.(2);Squeox7x7x7 F.(2);Savinox7x7x7 F.(2);Noviellix7x7x7 D.(2);Forastierex7x7x7 D.(3);Principix7x7x7 M.R.D.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0237: Opportunity for action in Spanish IBD patients with Sub-optimal Disease Control: Subanalysis of IBD-PODCAST Study
Year: 2025
Source: ECCO'25
Authors: Gómezx7x7x7 E.(1);Rubiox7x7x7 S.(2);Suárezx7x7x7 P.(3);Verax7x7x7 M.I.(4);Paredesx7x7x7 J.M.(5);Hernández-Cambax7x7x7 A.(6);Plazax7x7x7 R.(7);Mañosax7x7x7 M.(8);Pajaresx7x7x7 R.(9);Siciliax7x7x7 B.(10);Maderox7x7x7 L.(11);Vegax7x7x7 P.(12);Huguetx7x7x7 J.M.(13);Santos de Lamadridx7x7x7 R.(14);Michelenax7x7x7 N.(14);Garcíax7x7x7 M.(14);Gomollón Garciax7x7x7 F.(15)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0238: Reliability of magnetic resonance imaging indices for evaluating perianal fistulizing disease activity in paediatric Crohn’s disease
Year: 2025
Source: ECCO'25
Authors: Crowleyx7x7x7 E.(1x7x7x72)*;Karpewyczx7x7x7 J.(3);Watsonx7x7x7 T.A.(4);Rimolax7x7x7 J.(5);Schneiderx7x7x7 R.(6);Alsabbanx7x7x7 Z.(7);Cytter-Kuintx7x7x7 R.(8);Max7x7x7 C.(2x7x7x79x7x7x710);Zoux7x7x7 G.(2x7x7x711);Lewindonx7x7x7 P.J.(12);Geex7x7x7 M.S.(13x7x7x714);Hyamsx7x7x7 J.S.(15);Rosenx7x7x7 M.J.(16);von Allmenx7x7x7 D.(17x7x7x718);de Buck van Overstraeten x7x7x7 A.(19);Shackeltonx7x7x7 L.(2);Rémillardx7x7x7 J.(2);Ashton x7x7x7 H.(2);Dillmanx7x7x7 J.R.(20x7x7x721);Taylorx7x7x7 S.A.(22);Fletcherx7x7x7 J.(23);Churchx7x7x7 P.C.(24);Feaganx7x7x7 B.(2x7x7x711x7x7x725);Griffithsx7x7x7 A.M.(24);Jairathx7x7x7 V.(2x7x7x711x7x7x725);Greerx7x7x7 M.L.C.(26x7x7x727);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0239: Sexual quality of life and patient-healthcare communication in Inflammatory Bowel Disease: a comprehensive single-center analysis
Year: 2025
Source: ECCO'25
Authors: Saidanix7x7x7 R.(1)*;Cherifx7x7x7 D.(1);Hassinex7x7x7 H.(1);Yacoubx7x7x7 H.(1);Debbabix7x7x7 H.(1);Kchirx7x7x7 H.(1);Maamourix7x7x7 N.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P023: A resting state fMRI study in patients with active Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Thapaliya1, S. Eldeghaidy2, S. J. Radford1, S. Francis2, G. Moran*1

Created: Friday, 22 February 2019, 9:41 AM
P023: Development of methods to investigate effects of narrow spectrum kinase inhibitors on cellular phosphorylation of kinase substrates
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Sirohi*, M. Foster, M. Fyfe, Y. Solanke, S. Webber, C. Walshe

Created: Friday, 22 February 2019, 9:49 AM
P023: Fatigue in quiescent inflammatory bowel disease is associated with low GM-CSF levels and metabolomic alterations
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Borren N.*1,2, Goel G.3,4, Lassen K.1, Devaney K.1, Cleland T.1, Garber J.1,4, Khalili H.1,4, Yajnik V.1,4, Xavier R.1,4, Ananthakrishnan A.1,4

Created: Wednesday, 20 February 2019, 10:36 AM
P023: Immune-metabolic profiles of creeping fat in relation to degree of severity in Crohn's disease postsurgical recurrence.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Suau, R.(1,2)*;Pardina, E.(3);López-Tejero, M.D.(3);Lorén, V.(1,2);Zabana, Y.(2,4);Llaves, M.(1);Cordobilla, B.(3);Cañete, F.(2,5);Guasch, M.(6);Ricart-Jané, D.(3);Mañosa, M.(2,5);Domènech, E.(2,5);Domingo, J.C.(3);Manyé, J.(1,2);
Created: Friday, 14 July 2023, 10:48 AM
P023: NOD2 support crypt survival and promote intestinal epithelial regeneration
Year: 2018
Source: ECCO '18 Vienna
Authors:

S.N. Hong*, C. Lee, T.J. Kim, E.R. Kim, D.K. Chang, Y.-H. Kim

Created: Thursday, 21 February 2019, 9:14 AM
P023: Prevalence of malnutrition, risk of malnutrition and quality of life among patients with Inflammatory Bowel Disease.
Year: 2022
Source: ECCO'22
Authors: Korwel, K.M.(1);Hjortswang , H.(1);Eberhardson , M.(1);Pihl Lesnovska, K.(1);
Created: Friday, 11 February 2022, 3:52 PM
P023: SZN-1326, a Wnt agonist, improved epithelial healing and ameliorated colitis in a chronic DSS model, in stark contrast to anti-TNF and anti-IL-12/23p40 antibodies
Year: 2021
Source: ECCO'21 Virtual
Authors: Xie, L.(1);Handa, P.(1);Tun, C.(1);Liu, A.(1);Lu, C.(2);Baribault, H.(1);Newman, M.(3);Le, L.(3);Shah, D.(2);Deshmukh, S.(2);Mutha, D.(1);Le, T.(1);Fletcher, R.(2);Chen, H.(4);Ye, J.(4);Tibbitts, J.(3);Srinivasan, U.(3);Li, Y.(4);Vanhove, G.(3);Yeh, W.C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P024 Evaluation of the clinical course of patients diagnosed with primary sclerosing cholangitis: single centre study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Wiecek1, A. Wojtyniak2, B. Pindur2, U. Grzybowska-Chlebowczyk1

Created: Thursday, 30 January 2020, 10:12 AM
P0240: Cross-cultural adaptation and validation of the Crohn’s Anal Fistula – Quality of Life scale in Dutch patients with active perianal fistulizing Crohn’s disease
Year: 2025
Source: ECCO'25
Authors: Bakx7x7x7 M.T.J.(1);Pierikx7x7x7 R.J.(1)*;Rizopoulosx7x7x7 D.(2);Buskensx7x7x7 C.J.(3);van der Biltx7x7x7 J.D.W.(4);de Boerx7x7x7 N.K.H.(5);Gecsex7x7x7 K.B.(5);Mundtx7x7x7 M.W.(6);Witjesx7x7x7 C.D.M.(7);Fitzpatrickx7x7x7 C.E.(8);Nissenx7x7x7 L.H.C.(9);Verdaasdonkx7x7x7 E.G.G.(10);Hoogenboomx7x7x7 F.J.(11);Visschedijkx7x7x7 M.C.(12);Stassenx7x7x7 L.P.S.(13);van Rulerx7x7x7 O.(14);de Vriesx7x7x7 A.C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0241: The DETECTION Study: DETection by Endoscopy of Colitis in Screening ImplementaTION
Year: 2025
Source: ECCO'25
Authors: Lloydx7x7x7 A.(1)*;Hanlyx7x7x7 M.(1);Nolanx7x7x7 B.(1);Doranx7x7x7 R.(1);McCarvillex7x7x7 L.(1);Macmathunax7x7x7 P.(1);Coffeyx7x7x7 H.(1);Adetonax7x7x7 O.(1);Rajanx7x7x7 M.(1);Dokicx7x7x7 D.(1);Manjx7x7x7 J.(1);Morahanx7x7x7 F.(1);Luceyx7x7x7 M.(1);Walshx7x7x7 N.(1);Musial x7x7x7 O.(1);Sugruex7x7x7 K.(1);Twomeyx7x7x7 R.(1);O'Sullivanx7x7x7 C.(1);O'Brienx7x7x7 L.(1);Gleesonx7x7x7 S.(1);Sheehanx7x7x7 D.(1);McDonaldx7x7x7 C.(1);Moranx7x7x7 C.(1);Buckleyx7x7x7 M.(1);Iacuccix7x7x7 M.(1);McDermottx7x7x7 E.(1);Cullenx7x7x7 G.(1);Horganx7x7x7 G.(1);Mulcahyx7x7x7 H.(1);Buckleyx7x7x7 M.(1);Sheridanx7x7x7 J.(1);Eganx7x7x7 L.(1);Kevansx7x7x7 D.(1);McCarthyx7x7x7 J.(1);Leydanx7x7x7 J.(1);O'Toolex7x7x7 A.(1);Macnamarax7x7x7 D.(1);Slatteryx7x7x7 E.(1);Bolandx7x7x7 K.(1);Dohertyx7x7x7 G.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0242: Improving quality in IBD – evaluation of corticosteroid excess prescription trends and its predictive role in disease-related outcomes
Year: 2025
Source: ECCO'25
Authors: Damascenox7x7x7 J.(1)*;Guimarãesx7x7x7 A.(1);Carvalhox7x7x7 T.(1);Nevesx7x7x7 J.(1);Arrojax7x7x7 B.(1);Soaresx7x7x7 J.(1);Rebelox7x7x7 A.(1);Mendesx7x7x7 S.(1);Gonçalvesx7x7x7 R.(1);Tiagox7x7x7 L.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0243: Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD).
Year: 2025
Source: ECCO'25
Authors: Oliveirax7x7x7 E.C.S.D.(1)*;Lopesx7x7x7 M.A.(1);Beraldox7x7x7 R.F.(1);Castelhanox7x7x7 N.S.(1);Baimax7x7x7 J.P.(1);Herrerias x7x7x7 G.S.P.(1);Quagliox7x7x7 A.E.V.(2);Di Stasix7x7x7 L.C.(3);Barbosax7x7x7 W.F.(1);Silva x7x7x7 G.F.(1);Sassakix7x7x7 L.Y.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0244: Serum IgLC Levels in Ulcerative Colitis: Limited Utility as Biomarkers for Disease Activity
Year: 2025
Source: ECCO'25
Authors: Ohx7x7x7 J.E.(1)*;Parkx7x7x7 J.J.(1);Choix7x7x7 S.(1);Parkx7x7x7 J.(1);Parkx7x7x7 S.J.(1);Kimx7x7x7 T.I.(1);Cheonx7x7x7 J.H.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0245: Analysis of quality measurements of colonoscopy at different levels of care in IBD
Year: 2025
Source: ECCO'25
Authors: Bacsur x7x7x7 P.(1);Farkas x7x7x7 B.(1);Ivány x7x7x7 E.(1);Fábián x7x7x7 A.(1);Bor x7x7x7 R.(1);Szepes x7x7x7 Z.(1);Farkas x7x7x7 K.(1x7x7x72);Molnár x7x7x7 T.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session